Share this article
Share this article
SAN CARLOS, Calif. and BOULDER, Colo., May 26, 2021 /PRNewswire/ Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, and Addario Lung Cancer Medical Institute (ALCMI) today announced they will present on the progress of Biomarker Analysis in High PD-L1 Expressing NSCLC Patients Treated With PD-1/PD-L1 Based Therapy With or Without the Addition of Platinum Based Chemotherapy (BEACON-Lung). The BEACON-Lung study aims to evaluate biomarkers to predict overall survival and early progression outcomes in treatment-naïve advanced stage non-small cell lung cancer (NSCLC) patients with high PD-L1 expression. The first patient participant enrolled in the study this week.
How can we improve treatment for lung cancer? Dr. Matt Kinsey and a collaborative, multidisciplinary team at the University of Vermont Cancer Center are a new technique: delivering treatment directly to the tumor using a state-of-the-art robotic device. (Paid Post)
The show will air at 12 p.m. Dr. Weiskopf will reflect on her career serving patients with migraines, epilepsy, stroke, multiple sclerosis (MS), Parkinson s disease, and other conditions of the brain, spinal cord, and nervous system. The show is produced with cooperation from Catamount Access Television (CAT-TV). Viewers can see Medical Matters Weekly on Facebook at facebook.com/svmedicalcenter and facebook.com/CATTVBennington. Dr. Weiskopf received her medical degree from Albert Einstein College of Medicine in New York. She completed her residency at Mount Sinai Medical Center in New York and served as chief resident 2005 – 2006 before going on to a fellowship at New York University Medical Center 2006 – 2007. Dr. Wieskopf had been an attending neurologist at Berkshire Medical Center in Massachusetts 2008 – 2019. She is board certified by the American Board of Psychiatry and Neurology.
This 2021 Recommendation Statement from the US Preventive Services Task Force recommends that clinicians offer pregnant persons effective behavioral counseling
How Doulas and Midwives Can Help Combat the Racial Biases of Western Medicine
0 Shares
American mothers die in childbirth at a greater rate than mothers in all other developed countries three times more than in Britain and Canada, for instance, according to a 2018 report by NPR and ProPublica. Additionally, for every woman who dies during labor in the US, at least 70 experience complications that bring them close to death. In other words, a mother quite literally puts her whole existence on the line anytime she tries to bring life into the world.
Peter Bernstein, MD, MPH, program director of the Department of Obstetrics and Gynecology and Women s Health Maternal Fetal Medicine at the Albert Einstein College of Medicine, and chair of The Council on Patient Safety in Women s Health Care, outlines some of the risks and hazards associated with childbirth in that same NPR report: Women can wind up losing their uterus and therefore becoming infertile. They can wind up with kidney p